<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two cases of cytomegalovirus (CMV) <z:e sem="disease" ids="C0035333" disease_type="Disease or Syndrome" abbrv="">retinitis</z:e> following bone marrow transplantation (BMT) from unrelated donors are reported </plain></SENT>
<SENT sid="1" pm="."><plain>1 patient had been treated for severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) and the other for hypoplastic <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Because first line therapy with antithymocyte globulin (ATG) and <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> (CsA) had failed, BMT was performed following a conditioning regimen of ATG, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, and total lymphoid irradiation </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment for <z:e sem="disease" ids="C0206178" disease_type="Disease or Syndrome" abbrv="">CMV retinitis</z:e> was successfully carried out with <z:chebi fb="1" ids="465284">gancyclovir</z:chebi> (systemic and intraocular injection), foscarnet, and photocoagulation (Case 1) and <z:chebi fb="1" ids="465284">gancyclovir</z:chebi> and foscarnet (Case 2) </plain></SENT>
<SENT sid="4" pm="."><plain>Both patients also developed Epstein-Barr virus-associated <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e> (EBV-LPD) </plain></SENT>
<SENT sid="5" pm="."><plain>We compared these 2 cases with 14 SAA patients who did not develop <z:e sem="disease" ids="C0206178" disease_type="Disease or Syndrome" abbrv="">CMV retinitis</z:e> after BMT using marrow from either HLA-identical siblings (n = 9) or from unrelated donors (n = 5) </plain></SENT>
<SENT sid="6" pm="."><plain>Unlike the <z:e sem="disease" ids="C0035333" disease_type="Disease or Syndrome" abbrv="">retinitis</z:e> patients, the latter 5 patients received ATG only once </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:e sem="disease" ids="C0035333" disease_type="Disease or Syndrome" abbrv="">retinitis</z:e> patients had significantly lower CD4+ T-cell levels in their peripheral blood than the 14 patients who did not develop <z:e sem="disease" ids="C0206178" disease_type="Disease or Syndrome" abbrv="">CMV retinitis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>We believe that repeated treatment with ATG and transplantation from unrelated donors may lead to <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune dysfunction</z:e> that could increase the likelihood of <z:e sem="disease" ids="C0206178" disease_type="Disease or Syndrome" abbrv="">CMV retinitis</z:e>, as well as LPD </plain></SENT>
<SENT sid="9" pm="."><plain>For such BMT patients, regular ophthalmic examinations and careful testing for CMV antigenemia are recommended </plain></SENT>
</text></document>